TB-500 vs LL-37

Overview

TB-500 and LL-37 are both peptides studied for wound healing but with fundamentally different origins and mechanisms. TB-500 is a fragment of thymosin beta-4 with claimed tissue repair effects, while LL-37 is the human cathelicidin with established antimicrobial and wound healing properties.

Key Facts

Aspect	TB-500	LL-37
Parent Molecule	Thymosin beta-4	Cathelicidin hCAP18
Structure	43 amino acids	37 amino acids
Origin	Fragment of natural peptide	C-terminal of cathelicidin
Natural Occurrence	Derived from Tβ4	Produced by immune cells
FDA Status	Not approved	Not approved

Mechanism Comparison

Aspect	TB-500	LL-37
Primary Mechanism	Actin regulation (claimed)	Antimicrobial, immunomodulation
Wound Healing	Proposed	Well-documented
Antimicrobial	No	Yes (primary function)
Immune Effects	Not characterized	Significant

How They Work

TB-500:

• Contains actin-binding sequence from thymosin beta-4
• Proposed to enhance cell migration
• May promote angiogenesis
• Mechanism extrapolated from parent compound

LL-37:

• Disrupts microbial membranes
• Modulates immune cell activity
• Promotes keratinocyte migration
• Stimulates angiogenesis
• Well-characterized mechanism

Evidence Comparison

Aspect	TB-500	LL-37
Human Trials	None for TB-500	Some
Animal Studies	Tβ4 has data	Extensive
Independent Research	Limited	Multiple groups
Mechanism Studies	Extrapolated	Direct

Critical Difference

TB-500: Evidence extrapolated from thymosin beta-4 research; TB-500 specifically has minimal direct study.

LL-37: Directly studied with clear mechanisms and multiple research groups contributing.

Proposed/Established Effects

TB-500 (Claimed, Not Verified)

Effect	Evidence Basis
Cell migration	From Tβ4 studies
Wound healing	From Tβ4 studies
Angiogenesis	From Tβ4 studies
Muscle repair	Anecdotal/animal
Anti-inflammatory	Limited

LL-37 (Documented)

Effect	Evidence Level
Antimicrobial activity	Well-established
Wound healing	Human and animal data
Immunomodulation	Extensively characterized
Angiogenesis	Demonstrated
Anti-biofilm	Demonstrated

Research Quality

Factor	TB-500	LL-37
Direct Studies	Very few	Numerous
Research Groups	Limited	Many worldwide
Peer Review	Limited	Extensive
Mechanism Clarity	Poor	High

Applications

Application	TB-500	LL-37
Sports Recovery	Primary claim	Not used
Wound Healing	Claimed	Research focus
Infection	Not applicable	Primary use
Chronic Wounds	Claimed	Being developed
Burns	Limited	Research ongoing

Safety Profile

TB-500

Aspect	Status
Human Safety Data	None
Long-term Effects	Unknown
Quality Control	None
Cancer Concerns	Theoretical (angiogenesis)

LL-37

Aspect	Status
Human Safety Data	Some available
Natural Peptide	Endogenously produced
Concentration Limits	High doses can be toxic
Therapeutic Window	Being defined

Regulatory Status

Aspect	TB-500	LL-37
FDA Status	Not approved	Not approved
Development Interest	None	Active
WADA Status	Prohibited	Not listed
Availability	Research chemical	Research chemical

Key Differences

Factor	TB-500	LL-37
Evidence quality	Very low	Moderate-high
Mechanism clarity	Poor	High
Antimicrobial	No	Yes
Research base	Extrapolated	Direct
Drug development	None	Active interest
WADA status	Prohibited	Not prohibited

Wound Healing Comparison

Factor	TB-500	LL-37
Cell Migration	Claimed	Demonstrated
Angiogenesis	Claimed	Demonstrated
Anti-infection	No	Yes
Evidence Base	Weak	Stronger

LL-37 has added benefit of antimicrobial activity in wound environment.

Summary

• TB-500 has claimed tissue repair effects based on thymosin beta-4 research, but TB-500 specifically lacks direct evidence
• LL-37 is a well-characterized human peptide with established antimicrobial and wound healing properties
• LL-37 has significantly stronger scientific foundation
• TB-500 is prohibited in sport; LL-37 is not
• LL-37 has active pharmaceutical development interest
• Neither is FDA-approved; both available as research chemicals with quality concerns

---

This comparison is for educational purposes only. Neither peptide is approved for therapeutic use. TB-500 is a prohibited substance in sport. Products sold as research chemicals have unknown quality and safety.